Regis Custom Pharma Oncology Capabilities

The need to fast-track breakthrough discoveries in oncology has never been more imperative and regulatory agencies are accelerating approval of novel oncology drugs at an unprecedented rate. Oncology continues to be one of the largest growing markets for drug development creating a need for the rapid development of novel, potent, drug substances. Since 2016, over 200 new oncology drugs have been approved and thousands of clinical trials conducted. Continued growth is expected with a combined annual growth rate of 8% through 2028 particularly in the field of oncology.

Download to learn more about Regis Custom pharma capabilities and how we can help develop and expedite your oncology drug candidate to market fast.